A carregar...
Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside
Since the clear demonstration of lysophosphatidic acid (LPA)’s pathological roles in cancer in the mid-1990s, more than 1000 papers relating LPA to various types of cancer were published. Through these studies, LPA was established as a target for cancer. Although LPA-related inhibitors entered clini...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6826372/ https://ncbi.nlm.nih.gov/pubmed/31658655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11101523 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|